Oxford Finance Corporation Closes $25 Million Credit Facility with EUSA Pharma
2/4/2010 11:26:56 AM
More...
|
NovaMed Pharmaceuticals Inc. Expands Cardiovascular and Oncology Pipelines with the Signing of Two New Agreements with Iroko Pharmaceuticals And EUSA Pharma
7/10/2009 11:09:31 AM
More...
|
EUSA Pharma Completes the European Launch of CAPHOSOL(R) for Prevention and Treatment of Oral Mucositis Caused by Cancer Therapy
3/31/2009 8:32:57 AM
More...
|
CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation; New Data Underscore the Utility of CAPHOSOL in Treating Oral Mucositis
5/22/2008 9:28:07 AM
More...
|
Helicon Group Secures Exclusive China Rights For Collatamp G, An Innovative Drug Release Surgical Implant
5/12/2008 4:22:02 PM
More...
|
EUSA Pharma Completes Acquisition Of Cytogen Corporation (CYTO)
5/9/2008 6:54:47 AM
More...
|
EUSA Pharma Divests Monoclonal Antibody Research Business and Early-Stage Oncology Product
5/1/2008 7:03:21 AM
More...
|
Samaritan Pharmaceuticals, Inc. (SPHC) Signs Exclusive License to Commercialize Two of EUSA Pharma's Marketed Oncology Drugs in Greece and Cyprus
3/11/2008 10:25:57 AM
More...
|
EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to GlaxoSmithKline (GSK) for up to $44 Million Plus Royalties
2/18/2008 6:27:18 AM
More...
|
EUSA Pharma Announces $30 Million Debt Facilty
12/12/2007 10:32:43 AM
More...
|
|